Clinical Trials Browser

Phase 1 × Active not recruiting × umbralisib × Clear all

NCT03283137 2025-02-07

Combination of Pembrolizumab With TGR-1202 in Patients With Relapsed/Refractory CLL and B-cell NHL

Phase 1 Active not recruiting

Lymphoma, B-Cell